3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
1
Breast
1
Conditions
Breast Neoplasms
16
Neoplasms
4
Neoplasm Metastasis
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Giant Cell Tumor of Bone
3
Carcinoma, Renal Cell
3
Smoldering Multiple Myeloma
2
Recurrence
2
Osteoporosis
2
Melanoma
2
Kidney Neoplasms
2
Bone Cysts, Aneurysmal
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Cancer Metastatic
1
Parathyroid Neoplasms
1
Osteoporotic Fractures
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Osteoblastoma
1
Neoplastic Cells, Circulating
1
Musculoskeletal Pain
1
Mastocytosis, Systemic
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hyperparathyroidism, Primary
1
Granuloma, Giant Cell
1
Giant Cell Tumors
1
Interventions
Zoledronic Acid
8
Vitamin D
6
Risedronic Acid
6
Calcium
6
Letrozole
4
Cholecalciferol
4
Calcium Carbonate
4
Alendronate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Nutrition Assessment
2
Goserelin
2
Estradiol
2
Denosumab
2
Calcium Gluconate
2
Aromatase Inhibitors
2
Absorptiometry, Photon
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Technetium
1
Raloxifene Hydrochloride
1
Progesterone
1
Parathyroid Hormone-Related Protein
1
Parathyroid Hormone
1
Lysine Acetyltransferase 5
1
Ibandronic Acid
1
Hormone Replacement Therapy
1
Geritol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Osteoporosis
×
Denosumab
×
Clear all
NCT03401060
2026-03-31
DenosuMast
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
24 enrolled
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled